Be‐Sheng Kuo
National Cheng Kung University(TW)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, HER2/EGFR in Cancer Research, Neuropeptides and Animal Physiology, Glycosylation and Glycoproteins Research
Most-Cited Works
- → UB‐311, a novel UBITh ® amyloid β peptide vaccine for mild Alzheimer's disease(2017)139 cited
- → The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret(1997)54 cited
- → IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms(2022)51 cited
- → Effects of sulfonylureas on the synthesis and secretion of plasminogen activator from bovine aortic endothelial cells.(1988)20 cited
- → Column-switching high-performance liquid chromatographic (HPLC) determination of hydrochlorothiazide in rat, dog, and human plasma.(1990)20 cited
- → Absorption of Cam-2445, an NK1 Neurokinin Receptor Antagonist: In Vivo, In Situ, and In Vitro Evaluations(1996)16 cited
- → Influence of Nicotine and Cotinine on the Expression of Plasminogen Activator Activity in Bovine Aortic Endothelial Cells(1989)15 cited
- → Role of polyamines in the stimulation of synthesis and secretion of plasminogen activator from bovine aortic endothelial cells(1988)12 cited
- → Sample pooling to enhance throughput of brain penetration study(1999)12 cited
- → Development and Validation of Two Solid-Phase Enzyme Immunoassays (ELISA) for Quantitation of Human Epidermal Growth Factors (hEGFs)(1996)10 cited